colchicine to be investigated as a possible treatment for covid-19 in the icu trial
colchicine to be investigated as a possible treatment for covid-19 in the icu trial
by including colchicine in the recovery trial, we will be able to establish whether it helps tackle the worst consequences of covid-19. it is anticipated that at least 2500 patients recruited to the recovery trial will be randomly allocated to receive colchicine plus usual standard-of-care, and results will be compared with at least 2500 patients who receive the usual standard-of-care on its own.